SUSAN VOSS: Open Payments
NPI 1558379735 · LOUISIANA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,419 in 50 payments from 15 companies in 2025. Trend: 2023 $1,449 · 2024 $1,634 · 2025 $1,419
Food & beverage: $1,320Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $296 |
| ABBVIE INC. | 9 | $218 |
| Lilly USA, LLC | 6 | $185 |
| Galderma Laboratories, L.P. | 5 | $181 |
| Novartis Pharmaceuticals Corporation | 6 | $179 |
| Amgen Inc. | 4 | $83 |
| Organon LLC | 2 | $47 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $46 |
| Incyte Corporation | 2 | $43 |
| UCB, Inc. | 2 | $40 |
Products named: TREMFYA, NEMLUVIO, RINVOQ, TALTZ, COSENTYX, EBGLYSS, SKYRIZI, OTEZLA.
Industry payments across MO — which companies pay providers there.
